![William Duke](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
William Duke
Finanzdirektor/CFO bei
INVIVYD, INC.
Vermögen: 161 335 $ am 31.08.2026
Profil
William E.
Duke is Chief Financial & Accounting Officer at Invivyd, Inc. since 2023.
Former roles include Chief Financial Officer at OTF Group, Inc.; Director-Finance & Accounting at Haemonetics Corp.
from 2008 to 2010; Senior Director-Finance at Genzyme Corp.
from 2010 to 2011; Chief Financial Officer at g8wave Holdings, Inc. from 2007 to 2008; Chief Financial Officer & Head-Investor Relations at Valeritas, Inc. in 2015; Chief Financial Officer, Secretary & Treasurer at Pulmatrix, Inc. from 2015 to 2019; Chief Financial & Accounting Officer at Kaleido Biosciences, Inc. from 2019 to 2022; and Chief Financial Officer at Apexigen, Inc. from 2022 to 2023.
Education includes an MBA from Bentley University and undergraduate studies at Stonehill College, Inc.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
INVIVYD, INC. 0.06% | 18.08.2026 | 168’937 ( 0.06% ) | 161 335 $ | 31.08.2026 |
Aktive Positionen von William Duke
| Unternehmen | Position | Beginn |
|---|---|---|
| INVIVYD, INC. | Finanzdirektor/CFO | 01.09.2023 |
Ehemalige bekannte Positionen von William Duke
| Unternehmen | Position | Ende |
|---|---|---|
| APEXIGEN, INC. | Finanzdirektor/CFO | 23.08.2023 |
| KALEIDO BIOSCIENCES, INC. | Finanzdirektor/CFO | 08.04.2022 |
| PULMATRIX, INC. | Finanzdirektor/CFO | 22.11.2019 |
| VALERITAS INC | Finanzdirektor/CFO | 01.06.2015 |
Genzyme Corp.
 Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Finanzdirektor/CFO | - |
Ausbildung von William Duke
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
61
Beziehungen ersten Grades
11
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 11 |
|---|---|
Haemonetics Corp.
 Haemonetics Corp. Medical SpecialtiesHealth Technology Designs, manufactures, markets and services blood processing systems | Health Technology |
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
g8wave Holdings, Inc.
 g8wave Holdings, Inc. Specialty TelecommunicationsCommunications Provides planning, creating and executing effective mobile marketing campaigns and content distribution strategies | Communications |
Bentley University
 Bentley University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Stonehill College, Inc.
 Stonehill College, Inc. Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
OTF Group, Inc.
 OTF Group, Inc. Miscellaneous Commercial ServicesCommercial Services Provides management consulting services | Commercial Services |
Valeritas, Inc.
 Valeritas, Inc. Medical SpecialtiesHealth Technology Develops and commercializes drug delivery solutions for the treatment of diabetes | Health Technology |
Pulmatrix, Inc.
 Pulmatrix, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals for pulmonary disease | Health Technology |
Kaleido Biosciences, Inc.
 Kaleido Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biotechnology company which develops therapeutic products to systematically shape the micro biome | Health Technology |
Invivyd, Inc.
 Invivyd, Inc. BiotechnologyHealth Technology Develops antibody-based solutions for infectious diseases | Health Technology |
Apexigen, Inc.
 Apexigen, Inc. BiotechnologyHealth Technology Develops antibody therapeutics for the treatment of cancer | Health Technology |
